Zobrazeno 1 - 10
of 17
pro vyhledávání: '"33"'
Autor:
Varun Dhir, Shefali Khanna Sharma, Jasmina Ahluwalia, Ashwani Sood, Atit A Gawalkar, Aman Sharma, Ajay Bahl
Publikováno v:
Lupus. 29:1503-1508
Background Small case-series have reported overt myocardial dysfunction to be associated with positive antiphospholipid antibodies in patients of systemic lupus erythematosus (SLE). However, there is no case-control study that has examined this assoc
Autor:
Fulvia Ceccarelli, Guido Valesini, Francesca Romana Spinelli, Cristiana Barbati, Cristiano Alessandri, L. Novelli, Carlo Perricone, Fabrizio Conti, Roberto Perricone
Publikováno v:
Lupus. 28:621-628
BackgroundAdhesion molecule CD44 contributes to T cell migration into target organs. A higher expression of CD44v3 and v6 isoforms has been identified on T cells from systemic lupus erythematosus (SLE) patients. The aim of this study was to investiga
Publikováno v:
Lupus. 28(3)
Objective We analyzed data of lupus nephritis (LN) patients to find parameters that can predict remission. Methods Sixty-four LN patients who were diagnosed with class III, IV, V or V + III/IV by renal biopsy and were followed up for more than six mo
Autor:
Ziv Paz, George C. Tsokos, Chau Ching Liu, Borschukova O, Susan Manzi, J M Ahearn, Amy H. Kao, Ionita Ghiran
Publikováno v:
Lupus. 21:1294-1304
The complement system plays an important role in tissue inflammation and damage in SLE patients. High levels of C3d were detected on the surface of erythrocytes and lymphocytes of SLE patients. The objective of this study was to assess the functional
Publikováno v:
Lupus. 19:300-306
Neonatal lupus is a model of passively acquired autoimmunity whereby anti-SSA/Ro-SSB/La antibodies target the fetal heart and neonatal skin in a minority of cases. Since neuro-psychiatric impairment has been reported in humans and mice exposed prenat
Publikováno v:
Lupus. 18:713-717
The aim of this article is to compare the prevalence of anti-cyclic citrullinated peptide (anti-CCP) antibodies in systemic lupus erythematosus (SLE) patients with and without arthritis and in patients with rheumatoid arthritis (RA). Anti-CCP antibod
Publikováno v:
Lupus. 14:129-136
The antiphospholipid syndrome (APS) is characterized by the presence of antiphospholipid antibodies (aPL) in patients with thromboembolic complications. In APS, most aPL are autoantibodies to β2-glycoprotein I and prothrombin, which play a major rol
Publikováno v:
Lupus. 13:36-44
The objective of this paper is to investigate the association between patterns of anti-dsDNA antibody isotypes and specific clinical manifestations (categorized in renal, musculoskeletal, cutaneous, hematological, pulmonary, neurologicaland cardiac).
Publikováno v:
Lupus. 12:112-116
Thrombotic complications are a significant cause of morbidity and mortality in cancer patients. Studies in Caucasian populations have shown that up to one-third of such patients test positive to antiphospholipid antibodies. Our aim was to determine t
Autor:
G Tsariktsian, Ricardo Forastiero, L O Carreras, M M Sturno, B. Alonso, M. E. Martinuzzo, G F de Larrañaga
Publikováno v:
Lupus. 9:594-600
Antiphospholipid antibodies (aPL) have been reported not only in autoimmune disorders but also in various infectious diseases. Accumulating evidence indicates that b2glycoprotein I (b2GPI) and prothrombin are the main proteins to which autoimmune aPL